Background-Proinflammatory cytokines like tumor necrosis factor-alpha and o
xidative stress induce apoptotic cell death in endothelial cells (ECs). Sys
temic inflammation and increased oxidative stress in congestive heart failu
re (CHF) coincide with enhanced EC apoptosis and the development of endothe
lial dysfunction. Therefore, we investigated the effects of antioxidative v
itamin C therapy on EC apoptosis in CHF patients.
Methods and Results-Vitamin C dose dependently suppressed the induction of
EC apoptosis by tumor necrosis factor-a and angiotensin II in vitro as asse
ssed by DNA fragmentation, DAPI nuclear staining, and MTT viability assay.
The antiapoptotic effect of vitamin C was associated with reduced cytochrom
e C release from mitochondria and the inhibition of caspase-9 activity. To
assess EC protection by vitamin C in CHF patients, we prospectively randomi
zed CHF patients in a double-blind trial to vitamin C treatment versus plac
ebo. Vitamin C administration to CHF patients markedly reduced plasma level
s of circulating apoptotic microparticles to 32 +/-8% of baseline levels, w
hereas placebo had no effect (87 +/- 14%, P <0.005). In addition, vitamin C
administration suppressed the proapoptotic activity on EC of the serum of
CHF patients (P <0.001).
Conclusions-Administration of vitamin C to CHF patients suppresses EC apopt
osis in vivo, which might contribute to the established functional benefit
of vitamin C supplementation on endothelial function.